1. Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells
   Babak Nami et al, 2016, Bioimpacts CrossRef
2. Cancer Stem Cells as New Therapeutic Targets for Ovarian Cancer
   Y. Wang et al, 2016 CrossRef
3. MicroRNAs targeting prostate cancer stem cells
   Yu-Xiang Fang et al, 2015, Exp Biol Med (Maywood) CrossRef
4. A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib.
   Azmi Yerlikaya, 0 CrossRef
5. A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis.
   Azmi Yerlikaya, 0 CrossRef
6. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.
   Amy S Lee, 2014, Nat Rev Cancer CrossRef
7. Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice
   Amy S. Lee et al, 2017, Sci Rep CrossRef
8. Application of microRNA in diagnosis and treatment of ovarian cancer.
   Kouji Banno et al, 2014, Biomed Res Int CrossRef
9. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
   Neng Wang et al, 2014 CrossRef
10. GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents
    Nizar M. Mhaidat et al, 2016, Cytotechnology CrossRef
11. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
    Jie Xie et al, 2016, Biochemical and Biophysical Research Communications CrossRef
12. Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis
    Bahareh Bigdeli et al, 2016, Toxicology and Applied Pharmacology CrossRef
13. Effet de la radiothérapie sur les cellules souches cancéreuses de cancer du sein : résistance, reprogrammation et traitements
    J. Bailleul-Dubois et al, 2017, Oncologie CrossRef
14. Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor
    Suzanne J. Bakewell et al, 2018, Oncotarget CrossRef
15. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
    Cristina Talarico et al, 2016, Oncotarget CrossRef
16. The meta and bioinformatics analysis of GRP78 expression in gastric cancer
    Hua-Chuan Zheng et al, 2017, Oncotarget CrossRef
17. New insights into the unfolded protein response in stem cells
    Yanzhou Yang et al, 2016, Oncotarget CrossRef
18. Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy
    Alexander Kabakov et al, 2020, Cells CrossRef
19. A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement
    Leo Rasche et al, 2016, Clin Cancer Res CrossRef
20. Radiosensitization of calreticulin‐overexpressing human glioma cell line by the polyphenolic acetate 7, 8‐diacetoxy‐4‐methylcoumarin
    Amit Verma et al, 2021, Cancer Reports CrossRef
21. Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78
    Yan Zhong et al, 2022, Bioengineered CrossRef
22. Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence
    Bashar Alhasan et al, 2023, Cancer Metastasis Rev CrossRef
23. Cancer stem cells: advances in knowledge and implications for cancer therapy
    Xianjing Chu et al, 2024, Sig Transduct Target Ther CrossRef
24. The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target
    Lucette Z. Simbilyabo et al, 2024, CNS Neurosci Ther CrossRef
25. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
    Alexander E. Kabakov et al, 2021, Cells CrossRef